Cargando…
Hematological abnormalities and comorbidities are associated with COVID-19 severity among hospitalized patients: Experience from Bangladesh
BACKGROUND: The hematological abnormalities are assumed to be involved in the disease progression of COVID-19. However, the actual associations between specific blood parameters and COVID-19 are not well understood. Here we aimed to assess the correlations between hematological parameters and the se...
Autores principales: | Rahman, Md. Ashrafur, Shanjana, Yeasna, Tushar, Md. Ismail, Mahmud, Tarif, Rahman, Ghazi Muhammad Sayedur, Milan, Zahid Hossain, Sultana, Tamanna, Chowdhury, Ali Mohammed Lutful Hoq, Bhuiyan, Mohiuddin Ahmed, Islam, Md. Rabiul, Reza, Hasan Mahmud |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8315496/ https://www.ncbi.nlm.nih.gov/pubmed/34314447 http://dx.doi.org/10.1371/journal.pone.0255379 |
Ejemplares similares
-
Hematological Abnormalities and Comorbidities Are Associated With the Severity of Kidney Disease: A Hospital-Based Cross-Sectional Study in Bangladesh
por: Rahman, Md. Ashrafur, et al.
Publicado: (2022) -
The WHO announced COVID-19 is no longer a global public health emergency amid the spreading of arcturus variant: a correspondence evaluating this decision
por: Rahman, Md. Ashrafur, et al.
Publicado: (2023) -
The WHO has terminated global public health emergency for COVID-19 by the IHR Emergency Committee recommendation: potential impact analysis
por: Rahman, Md. Ashrafur, et al.
Publicado: (2023) -
Problematic internet use and depressive symptoms among the school‐going adolescents in Bangladesh during the COVID‐19 pandemic: A cross‐sectional study findings
por: Islam, Md. Rabiul, et al.
Publicado: (2022) -
Assessment of vaccine perception and vaccination intention of Mpox infection among the adult males in Bangladesh: A cross-sectional study findings
por: Islam, Md. Rabiul, et al.
Publicado: (2023)